Liver Biopsy Analysis Has a Low Level of Performance for Diagnosis of Intermediate Stages of Fibrosis
Authors:
- Thierry PoynardTPThierry Poynard
- Gilles LenaourGLGilles Lenaour
- Jean Christophe VaillantJVJean Christophe Vaillant
- Frederique CapronFCFrederique Capron
- Mona MunteanuMMMona Munteanu
- Daniel EyraudDEDaniel Eyraud
- Yen NgoYNYen Ngo
- Helmi M'KAdaHMHelmi M'KAda
- Vlad RatziuVRVlad Ratziu
- Laurent HannounLHLaurent Hannoun
- Frederic CharlotteFCFrederic Charlotte
- 1 June 2012
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 10 (6) , 657-663.e7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient DataPLOS ONE, 2012
- Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of ageBMC Gastroenterology, 2011
- Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis BCurrent Hepatitis Reports, 2011
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease†Hepatology, 2008
- Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis MarkersPLOS ONE, 2008
- Meta-analyses of FibroTest diagnostic value in chronic liver diseaseBMC Gastroenterology, 2007
- CYP2E1: from ASH to NASHHepatology Research, 2004
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis CHepatology, 2003
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996